Cargando…

Novel mutational landscapes and expression signatures of lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) is a major subtype of Non-Small Cell Lung Cancer. To increase our understanding of the LUSC pathobiology, we performed exome sequencing and RNA-seq in 16 murine carcinogen-induced LUSC tumors and 8 normal murine lung tissue samples. Additionally, we conducted sing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Donghai, Pan, Jing, Yin, Yuxin, Jiang, Hui, Szabo, Eva, Lubet, Ronald A., Wang, Yian, You, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800913/ https://www.ncbi.nlm.nih.gov/pubmed/29484121 http://dx.doi.org/10.18632/oncotarget.23716

Ejemplares similares

Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents
por: Xiong, Donghai, et al.
Publicado: (2016)

Airway brushing as a new experimental methodology to detect airway gene expression signatures in mouse lung squamous cell carcinoma
por: Pan, Jing, et al.
Publicado: (2018)

Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma
por: Zhou, Yu, et al.
Publicado: (2019)

Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer
por: Zhang, Qi, et al.
Publicado: (2017)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)

A gene expression signature of TREM2(hi) macrophages and γδ T cells predicts immunotherapy response
por: Xiong, Donghai, et al.
Publicado: (2020)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer
por: Xiong, Donghai, et al.
Publicado: (2018)

Chemoprevention of Lung Cancer with a Combination of Mitochondria-Targeted Compounds
por: Zhang, Qi, et al.
Publicado: (2022)

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023)

Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer
por: Xiong, Donghai, et al.
Publicado: (2019)

Reply to: “Inconsistent prediction capability of ImmuneCells.Sig across different RNA-seq datasets”
por: Xiong, Donghai, et al.
Publicado: (2021)

The landscape of driver mutations in cutaneous squamous cell carcinoma
por: Chang, Darwin, et al.
Publicado: (2021)

Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
por: Pan, Jing, et al.
Publicado: (2023)

Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
por: Mangalaparthi, Kiran K., et al.
Publicado: (2020)

Proteogenomic landscape of squamous cell lung cancer
por: Stewart, Paul A., et al.
Publicado: (2019)

Development of alternative splicing signature in lung squamous cell carcinoma
por: Yan, Jia-qing, et al.
Publicado: (2021)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma
por: Guo, Liang, et al.
Publicado: (2021)

Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications
por: Zhao, Jungang, et al.
Publicado: (2020)

Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
por: Gaykalova, Daria A., et al.
Publicado: (2014)

Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Quantitative Proteomic Profiling the Molecular Signatures of Annexin A5 in Lung Squamous Carcinoma Cells
por: Sun, Bing, et al.
Publicado: (2016)

Pulmonary Aerosol Delivery of Let‐7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment
por: Zhang, Qi, et al.
Publicado: (2021)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
por: Peng, Xinyi, et al.
Publicado: (2023)

Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
por: Pan, Jing, et al.
Publicado: (2019)

Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma
por: Cai, Xiuyu, et al.
Publicado: (2020)

Autophagy characteristics and establishment of autophagy prognostic models in lung adenocarcinoma and lung squamous cell carcinoma
por: Chen, Zhubei, et al.
Publicado: (2022)

Mutational signatures and the genomic landscape of betel quid chewing‐associated tongue carcinoma
por: Zhang, Weilong, et al.
Publicado: (2019)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Correction: Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
por: Gaykalova, Daria A., et al.
Publicado: (2020)

A novel immunogenomic prognostic signature in lung squamous carcinoma
por: Hou, Jili, et al.
Publicado: (2021)

Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva
por: Han, Mi-Ryung, et al.
Publicado: (2018)

An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma
por: Qian, Lvsheng, et al.
Publicado: (2022)

KRAS Mutations in Squamous Cell Carcinomas of the Lung
por: Acker, Fabian, et al.
Publicado: (2021)

Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients
por: Yan, Dan, et al.
Publicado: (2021)

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
por: Pan, Jing, et al.
Publicado: (2021)

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tqh61uct2r4a0qundrjm403ovm